CH383961A - Process for the preparation of novel derivatives of trioxo-2,4,6-piperidine - Google Patents

Process for the preparation of novel derivatives of trioxo-2,4,6-piperidine

Info

Publication number
CH383961A
CH383961A CH7208759A CH7208759A CH383961A CH 383961 A CH383961 A CH 383961A CH 7208759 A CH7208759 A CH 7208759A CH 7208759 A CH7208759 A CH 7208759A CH 383961 A CH383961 A CH 383961A
Authority
CH
Switzerland
Prior art keywords
sep
piperidine
trioxo
preparation
phenyl
Prior art date
Application number
CH7208759A
Other languages
French (fr)
Inventor
Redel Joseph
Original Assignee
Chimie Atomistique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chimie Atomistique filed Critical Chimie Atomistique
Publication of CH383961A publication Critical patent/CH383961A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)

Description

  

  



  Procédé de préparation de nouveaux dérivés de la trioxo-2, 4,   6-pipéridine   
 La présente invention a pour objet un procédé de préparation de nouveaux composés de la trioxo-2, 4, 6  pipéridine répondant à    la formule générale   (I)    illustrée à la fig. 1 du dessin annexé, dans laquelle Ri,   Rg, Rg et Rt    sont chacun un radical aryle, tel que phényle, ou alcoyle et notamment alcoyle inférieur, et   RÏ    est de l'hydrogène, un radical alcoyle, en particulier alcoyle inférieur, ou un radical   aminoalcoyl-N-    substitué ou non.



   Ces nouveaux composés sont utilisables comme matières premières pour la synthèse de nouveaux composés actifs. Ils jouissent en outre, par euxmêmes, de propriétés sédatives, anticonvulsivantes et hypnotiques que ron peut mettre à profit en médecine humaine ou vétérinaire.



   Le procédé de préparation de ces composés est caractérisé en ce qu'il consiste à condenser un chlorure de   cyanacétyle      disubstitué    de formule :
EMI1.1     
 avec un ester, éthylique par exemple, d'un acide acétique   disubstitué    de formule :
EMI1.2     
   Rt, R2, R3, R4    ayant les significations précitées, à cycliser ensuite le produit ainsi obtenu en trioxo-2, 4,   6-pipéridine    substituée, et éventuellement à traiter par un composé alcoylant pour substituer un radical   R,    ; à l'hydrogène.



   La fig. 2 du dessin annexé illustre en a), b), et c) les stades ci-dessus énumérés du présent procédé, qu'on reprendra ci-dessous. La condensation du chlorure de   cyanacétyle      disubstitué    (II) avec 1'ester éthylique de l'acide acétique   disubstitué    (III) se fait avantageusement par contact des réactifs à basse température en présence de   triphényl-méthyl    sodium.



   La cyclisation du cyano-ester   (IV)    ainsi obtenu en trioxo-2, 4,   6-pipéridine    substituée   (V)    se fait par chauffage à la température du bain-marie avec un mélange d'acide acétique et d'acide sulfurique.



   L'alcoylation éventuelle du composé   (V)    peut être réalisée d'une manière connue en soi au moyen   d'un    composé alcoylant   R    Y correspondant au radical alcoyle ou alcoylamino que l'on désire introduire. Ce composé alcoylant peut être notamment un sulfate d'alcoyle, un halogénure d'alcoyle ou d'aminoalcoyle.



   Les chlorures de   cyanacétyle      disubstitués      (II)    qui servent de point de départ au présent procédé peuvent être obtenus par réaction de l'acide correspondant, éventuellement synthétisé à partir   d'un    acide cyanacétique monosubstitué, avec le pentachlorure de phosphore.



   L'exemple suivant illustre l'invention :
   3-phényl-3-éthyl-5,      5-diméthyl-2,    4,   6-trioxo-pipéri-    dine (composé I, Ri =   C6H ,      3, R2    =   C2HÏn    R3 = R4 = CH3, R5 =   H).    a) Préparation du   2-phényl-2-éthyl-2-cyano-acétyl-    isobutyrate d'éthyle (Composé   IV).   



   A une solution de   triphényl-méthyl    sodium   prépa-    rée de la manière habituelle (W. B. Renfrow, C. R.



  Hauser, Organic Syntheses, 1939,   19,    83), à partir de 50 g de chlorure de   triphénylméthyle,    on ajoute 21, 2 g   d'isobutyrate    d'éthyle   (ion.    Quand le mélange s'est décoloré-ce qui demande environ 10 minutes   -on    ajoute en une seule fois, au bain de glace :
 Chlorure de   phényl-éthyl-cyanacétyle      (II)....      38    g.



   On abandonne au repos une demi-heure au bain de glace, puis une heure à température ambiante. 



  Après reprise par Peau et traitement usuel, on recueille la fraction neutre brute, soit 85 g. On élimine la majeure partie du   triphényl-méthane    par précipitation à l'éther de pétrole (160 cm3). Les eaux mères, après concentration, sont reprises par 60 cm3 de méthanol glacé qui précipite encore un peu de triphényl-méthane dont on recueille au total 35 g. Le dernier filtrat est concentré et distillé. On recueille la fraction :
 Eo,   o.      mm = 118-127 ,    pesant 40, 4 g qui constitue le produit cherché, encore souillé   d'un    peu de   triphényl-méthane.    b) Cyclisation.



   36, 8 g du distillat précédent, additionnés de 37 cm3 d'acide acétique et de 37 cm3 d'acide sulfurique sont portés au bain-marie pendant 5 heures. On coule ensuite le mélange sur glace pilée et alcalinise le mélange en présence de glace. La suspension ainsi obtenue est filtrée, et le filtrat précipité par barbotage de gaz carbonique puis essoré. On recueille ainsi la 3-phÚnyl-3-Úthyl-5, 5-dimethyl-2, 4,   6-trioxo-pipéridine    brute, pesant 22, 2 g et fondant à   68-730    C. Par cristallisation dans l'hexane on obtient le produit pur sous forme de cristaux blancs.



   F =   78-80o    C
EMI2.1     


<tb>  <SEP> 69, <SEP> 30
<tb> C <SEP> % <SEP> 69, <SEP> 34 <SEP> calc. <SEP> 69, <SEP> 5
<tb>  <SEP> 6, <SEP> 69
<tb>   H <SEP> % <SEP> 6,    <SEP> 71 <SEP> calc. <SEP> 6, <SEP> 56
<tb>  <SEP>    5,    <SEP> 40
<tb> N <SEP> % <SEP> 5, <SEP> 44 <SEP>    calc.    <SEP> 5, <SEP> 41
<tb>  c) Alcoylation.
 l, 5,   5-triméthyl-3-phényl-3-éthyl-2,    4,   6-trioxo-pipé-    ridine (composé   I,    Ri =   CGHS,      R2 =      C2H ,      R3    =   R.   



     = R  = CH3)   
 On dissout 0, 52 g de sodium dans 20 cm3   d'étha-    nol absolu puis on ajoute successivement :
 5, 9 g de   3-phényl-3-éthyl-5,    5-dimethyl-2, 4,   6-tri-      oxo-pipéridine    obtenue selon b).



   4, 9 g ou 2, 1 cm3   d'iodure    de méthyle, après quoi l'on porte 6 heures au reflux, on concentre à sec, on reprend par de la soude normale et on extrait à l'éther. Après séchage et élimination du solvant, on recueille une huile cristallisant par trituration au bain de neige carbonique.
 p   = 5, 5 g       Rt= 88 %   
 F =   35-37O    C
 Par cristallisation dans l'éther de pétrole léger, on obtient le produit pur :

  
 F = 46-47¯ C
EMI2.2     


<tb>  <SEP> 70, <SEP> 39
<tb> C <SEP> % <SEP> 70, <SEP> 70, <SEP> calc. <SEP> 70, <SEP> 30 <SEP> %
<tb>  <SEP>    7,    <SEP> 04
<tb>   H <SEP> % <SEP> 7,    <SEP> 07 <SEP>    calc.    <SEP> 6, <SEP> 96 <SEP> %
<tb>  <SEP>    5,    <SEP> 12
<tb> N <SEP> % <SEP> 5, <SEP> 09 <SEP>    calc.    <SEP> 5, <SEP>    13 <SEP> %    <SEP> 
<tb>  c') Alcoylation.



   1-   (bêta-diméthyl-aminoéthyl)-3-phényl-3-éthyl-5,    5-dimethyl-2, 4,   6-trioxo-pipéridine.    (Composé I,   Rt    =   C6Hó,    , R2 = C2H5, R3 = R4   =    CH3,   R = (CHg) g      -N (CH.   



   Ce composé est préparé sous forme de chlorhydrate de la manière suivante.



   On dissout 2, 9 g de sodium dans 60 cm3   d'éthanol    absolu puis ajoute successivement : 3-phenyl-3-Úthyl-5, 5-dimÚthyl-2, 4, 6-trioxo
   pipéridine    14, 4 g
Chlorhydrate de chlorure de   diméthyl-amino-   
 éthyle 9, 6 g et porte au reflux pendant 8 heures. On jette ensuite dans un grand volume d'eau et sépare une fraction basique de la manière habituelle. On obtient ainsi 12 g d'une huile.

   Cette huile est dissoute dans   l'étha-    nol absolu et traitée par un excès d'acide chlorhydrique   éthanolique.    Après concentration à sec, on obtient le produit cherché.
 p =13g
 Rt = 64%
 Par cristallisation dans racétone, on obtient le produit pur :
 F =   169-1700 C   
EMI2.3     


<tb>  <SEP> 62, <SEP> 40
<tb>   C <SEP> %    <SEP> 62, <SEP> 35 <SEP> calc. <SEP> 62, <SEP> 21
<tb>  <SEP> 7, <SEP> 52
<tb> H% <SEP> 7, <SEP> 47 <SEP> calc. <SEP> 7, <SEP> 37
<tb>  <SEP> 7, <SEP> 51
<tb> N% <SEP> 7, <SEP> 55 <SEP> calc. <SEP> 7, <SEP> 64
<tb>  <SEP> 9, <SEP> 63
<tb> Cl <SEP> % <SEP> 9, <SEP> 71 <SEP> calc. <SEP> 9, <SEP> 70
<tb> 




  



  Process for the preparation of novel derivatives of trioxo-2, 4, 6-piperidine
 The subject of the present invention is a process for preparing new compounds of trioxo-2, 4, 6 piperidine corresponding to the general formula (I) illustrated in FIG. 1 of the accompanying drawing, in which R1, Rg, Rg and Rt are each an aryl radical, such as phenyl, or alkyl and in particular lower alkyl, and RI is hydrogen, an alkyl radical, in particular lower alkyl, or an substituted or unsubstituted aminoalkyl-N- radical.



   These new compounds can be used as raw materials for the synthesis of new active compounds. They also enjoy, by themselves, sedative, anticonvulsant and hypnotic properties that can be used in human or veterinary medicine.



   The process for preparing these compounds is characterized in that it consists in condensing a disubstituted cyanacetyl chloride of formula:
EMI1.1
 with an ester, ethyl for example, of a disubstituted acetic acid of formula:
EMI1.2
   Rt, R2, R3, R4 having the aforementioned meanings, then cyclizing the product thus obtained into trioxo-2, 4, 6-substituted piperidine, and optionally treating with an alkylating compound to substitute a radical R,; to hydrogen.



   Fig. 2 of the accompanying drawing illustrates in a), b), and c) the above-enumerated stages of the present process, which will be repeated below. The condensation of the disubstituted cyanacetyl chloride (II) with the ethyl ester of disubstituted acetic acid (III) is advantageously carried out by contact with the reagents at low temperature in the presence of triphenyl-methyl sodium.



   The cyclization of the cyano-ester (IV) thus obtained into substituted trioxo-2, 4, 6-piperidine (V) is carried out by heating at the temperature of a water bath with a mixture of acetic acid and sulfuric acid.



   The possible alkylation of compound (V) can be carried out in a manner known per se by means of an alkylating compound R Y corresponding to the alkyl or alkyllamino radical which it is desired to introduce. This alkylating compound can in particular be an alkyl sulfate, an alkyl or aminoalkyl halide.



   The disubstituted cyanacetyl chlorides (II) which serve as a starting point for the present process can be obtained by reaction of the corresponding acid, optionally synthesized from a monosubstituted cyanacetic acid, with phosphorus pentachloride.



   The following example illustrates the invention:
   3-phenyl-3-ethyl-5, 5-dimethyl-2, 4, 6-trioxo-piperidine (compound I, R 1 = C6H, 3, R2 = C 2 HIN R3 = R4 = CH3, R5 = H). a) Preparation of ethyl 2-phenyl-2-ethyl-2-cyano-acetyl-isobutyrate (Compound IV).



   To a solution of triphenyl-methyl sodium prepared in the usual manner (W. B. Renfrow, C. R.



  Hauser, Organic Syntheses, 1939, 19, 83), from 50 g of triphenylmethyl chloride, 21.2 g of ethyl isobutyrate (ion. When the mixture has discolored - which requires approximately 10 minutes - add at once, to the ice bath:
 Phenyl-ethyl-cyanacetyl (II) chloride .... 38 g.



   It is left to stand for half an hour in an ice bath, then for one hour at room temperature.



  After taking up with water and the usual treatment, the crude neutral fraction, ie 85 g, is collected. Most of the triphenyl-methane is removed by precipitation with petroleum ether (160 cm3). The mother liquors, after concentration, are taken up in 60 cm 3 of ice-cold methanol which further precipitates a little triphenyl-methane, of which a total of 35 g is collected. The last filtrate is concentrated and distilled. We collect the fraction:
 Eo, o. mm = 118-127, weighing 40.4 g which is the desired product, still soiled with a little triphenyl-methane. b) Cyclization.



   36.8 g of the preceding distillate, added with 37 cm3 of acetic acid and 37 cm3 of sulfuric acid, are taken to a water bath for 5 hours. The mixture is then poured onto crushed ice and the mixture is basified in the presence of ice. The suspension thus obtained is filtered, and the filtrate precipitated by bubbling carbon dioxide gas and then filtered off. Crude 3-phÚnyl-3-Úthyl-5, 5-dimethyl-2, 4, 6-trioxo-piperidine is thus collected, weighing 22.2 g and melting at 68-730 C. By crystallization from hexane is obtained the pure product in the form of white crystals.



   F = 78-80o C
EMI2.1


<tb> <SEP> 69, <SEP> 30
<tb> C <SEP>% <SEP> 69, <SEP> 34 <SEP> calc. <SEP> 69, <SEP> 5
<tb> <SEP> 6, <SEP> 69
<tb> H <SEP>% <SEP> 6, <SEP> 71 <SEP> calc. <SEP> 6, <SEP> 56
<tb> <SEP> 5, <SEP> 40
<tb> N <SEP>% <SEP> 5, <SEP> 44 <SEP> calc. <SEP> 5, <SEP> 41
<tb> c) Alkoylation.
 1,5,5-trimethyl-3-phenyl-3-ethyl-2, 4, 6-trioxo-piperidine (compound I, R 1 = CGHS, R 2 = C2H, R 3 = R.



     = R = CH3)
 0.52 g of sodium is dissolved in 20 cm3 of absolute ethanol then the following are added successively:
 5, 9 g of 3-phenyl-3-ethyl-5, 5-dimethyl-2, 4, 6-tri-oxo-piperidine obtained according to b).



   4.9 g or 2.1 cm3 of methyl iodide, after which the mixture is refluxed for 6 hours, the mixture is concentrated to dryness, the residue is taken up in normal sodium hydroxide and extracted with ether. After drying and removing the solvent, an oil crystallizing is collected by trituration in a carbon dioxide snow bath.
 p = 5.5 g Rt = 88%
 F = 35-37O C
 By crystallization from light petroleum ether, the pure product is obtained:

  
 F = 46-47¯ C
EMI2.2


<tb> <SEP> 70, <SEP> 39
<tb> C <SEP>% <SEP> 70, <SEP> 70, <SEP> calc. <SEP> 70, <SEP> 30 <SEP>%
<tb> <SEP> 7, <SEP> 04
<tb> H <SEP>% <SEP> 7, <SEP> 07 <SEP> calc. <SEP> 6, <SEP> 96 <SEP>%
<tb> <SEP> 5, <SEP> 12
<tb> N <SEP>% <SEP> 5, <SEP> 09 <SEP> calc. <SEP> 5, <SEP> 13 <SEP>% <SEP>
<tb> c ') Alkoylation.



   1- (beta-dimethyl-aminoethyl) -3-phenyl-3-ethyl-5, 5-dimethyl-2, 4, 6-trioxo-piperidine. (Compound I, Rt = C6H6,, R2 = C2H5, R3 = R4 = CH3, R = (CHg) g -N (CH.



   This compound is prepared as the hydrochloride in the following manner.



   2.9 g of sodium are dissolved in 60 cm3 of absolute ethanol then added successively: 3-phenyl-3-Úthyl-5, 5-dimÚthyl-2, 4, 6-trioxo
   piperidine 14.4 g
Dimethyl-amino-chloride hydrochloride
 ethyl 9.6 g and refluxed for 8 hours. It is then poured into a large volume of water and a basic fraction is separated in the usual manner. 12 g of an oil are thus obtained.

   This oil is dissolved in absolute ethanol and treated with an excess of ethanolic hydrochloric acid. After concentration to dryness, the desired product is obtained.
 p = 13g
 Rt = 64%
 By crystallization from racetone, the pure product is obtained:
 F = 169-1700 C
EMI2.3


<tb> <SEP> 62, <SEP> 40
<tb> C <SEP>% <SEP> 62, <SEP> 35 <SEP> calc. <SEP> 62, <SEP> 21
<tb> <SEP> 7, <SEP> 52
<tb> H% <SEP> 7, <SEP> 47 <SEP> calc. <SEP> 7, <SEP> 37
<tb> <SEP> 7, <SEP> 51
<tb> N% <SEP> 7, <SEP> 55 <SEP> calc. <SEP> 7, <SEP> 64
<tb> <SEP> 9, <SEP> 63
<tb> Cl <SEP>% <SEP> 9, <SEP> 71 <SEP> calc. <SEP> 9, <SEP> 70
<tb>


 

Claims (1)

REVENDICATION Procédé de préparation de nouveaux composés de la trioxo-2, 4, 6-pipÚridine de formule générale : EMI2.4 dans laquelle Rl, R2, R3 et R4 sont chacun un radical aryle ou alcoyle, caractérisé en ce qu'il consiste à condenser un chlorure de cyanacétyle disubstitué de formule : EMI2.5 avec un ester d'un acide acétique disubstitué de formule : EMI3.1 Rl, R2, R3, R4 ayant les significations précitées, et à cycliser ensuite le produit ainsi obtenu en trioxo2, 4, 6-pipéridine substituée. CLAIM Process for the preparation of novel compounds of trioxo-2, 4, 6-pipÚridine of general formula: EMI2.4 in which Rl, R2, R3 and R4 are each an aryl or alkyl radical, characterized in that it consists in condensing a disubstituted cyanacetyl chloride of formula: EMI2.5 with an ester of a disubstituted acetic acid of the formula: EMI3.1 Rl, R2, R3, R4 having the aforementioned meanings, and then cyclizing the product thus obtained into substituted trioxo2, 4, 6-piperidine. SOUS-REVENDICATIONS 1. Procédé selon la revendication, caractérisé en ce que Rl, R2, R3 et R4 sont chacun un radical phényle ou alcoyle inférieur. SUB-CLAIMS 1. Method according to claim, characterized in that Rl, R2, R3 and R4 are each a phenyl or lower alkyl radical. 2. Procédé selon la revendication, caractérisé en ce que la condensation du chlorure de cyanacétyle disubstitué avec l'ester d'acide acétique disubstitué est effectuée par contact des réactifs à basse température en présence de triphényl-méthyl sodium. 2. Method according to claim, characterized in that the condensation of the disubstituted cyanacetyl chloride with the disubstituted acetic acid ester is carried out by contact of the reagents at low temperature in the presence of triphenyl-methyl sodium. 3. Procédé selon la revendication, caractérisé en ce que la cyclisation est effectuée par chauffage à la température du bain-marie avec un mélange d'acide acétique et d'acide sulfurique. 3. Method according to claim, characterized in that the cyclization is carried out by heating to the temperature of the water bath with a mixture of acetic acid and sulfuric acid. 4. Procédé selon la revendication, caractérisé en ce que l'on traite le composé cyclisé par un composé alcoylant pour introduire sur ratome d'azote en position 1 un radical alcoyle ou aminoalcoyle N-substitué ou non. 4. Method according to claim, characterized in that the cyclized compound is treated with an alkylating compound in order to introduce on the nitrogen ratome in position 1 an N-substituted or unsubstituted alkyl or aminoalkyl radical. 5. Procédé selon la sous-revendication 4, caracté- risé en ce que l'alcoylation du composé cyclisé est effectuée au moyen d'un sulfate d'alcoyle, d'un halo génure d'alcoyle, d'un halogénure d'aminoalcoyle, ou d'un halogénure d'aminoalcoyle-N-substitué. 5. Process according to sub-claim 4, characterized in that the alkylation of the cyclized compound is carried out by means of an alkyl sulfate, an alkyl halide, an aminoalkyl halide. , or an aminoalkyl-N-substituted halide. 6. Procédé selon la revendication pour la prépa- ration de la 3-phényl-3-éthyl-5, 5-diméthyl-2, 4, 6-tri- oxo-piperidine. 6. A process according to claim for the preparation of 3-phenyl-3-ethyl-5, 5-dimethyl-2, 4, 6-tri-oxo-piperidine. 7. Procédé selon la revendication et les sous-revendications 4 et 5 pour la préparation de la 1, 5, 5 triméthyl-3-phényl-3-éthyl-2, 4, 6 trioxo-pipéridine. 7. Process according to claim and sub-claims 4 and 5 for the preparation of 1, 5, 5 trimethyl-3-phenyl-3-ethyl-2, 4, 6 trioxo-piperidine. 8. Procédé selon la revendication et les sousrevendications 4 et 5 pour la préparation de la 1- (p diméthyl-aminoéthyl)-3-phényl-3-éthyl-5, 5-diméthyl- 2, 4, 6-trioxo-pipéridine. 8. A method according to claim and subclaims 4 and 5 for the preparation of 1- (p dimethyl-aminoethyl) -3-phenyl-3-ethyl-5, 5-dimethyl-2, 4, 6-trioxo-piperidine.
CH7208759A 1958-04-23 1959-04-15 Process for the preparation of novel derivatives of trioxo-2,4,6-piperidine CH383961A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR763939A FR1291512A (en) 1958-04-23 1958-04-23 New derivatives of trioxo-2, 4, 6-piperidine and their preparation process

Publications (1)

Publication Number Publication Date
CH383961A true CH383961A (en) 1964-11-15

Family

ID=8706325

Family Applications (1)

Application Number Title Priority Date Filing Date
CH7208759A CH383961A (en) 1958-04-23 1959-04-15 Process for the preparation of novel derivatives of trioxo-2,4,6-piperidine

Country Status (3)

Country Link
BE (1) BE577730A (en)
CH (1) CH383961A (en)
FR (1) FR1291512A (en)

Also Published As

Publication number Publication date
BE577730A (en) 1959-07-31
FR1291512A (en) 1962-04-27

Similar Documents

Publication Publication Date Title
EP0005689B1 (en) Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them
EP0486386B1 (en) Novel derivatives of N-benzoylproline, process for their preparation and drugs containing them
EP0139584B1 (en) Imidazoline derivatives, their preparation and therapeutical use
EP0148167B1 (en) Quinoline derivatives, process for their preparation and pharmaceutical compositions containing them
EP0092479B1 (en) N,n&#39;-substituted polymethylene diamines, processes for their preparation and pharmaceutical compositions containing them
EP0479631A1 (en) Spiro[4,5]decane derivatives, process for their preparation and pharmaceutical compositions containing them
EP0835254B1 (en) Oxazolidinone derivatives, their preparation and therapeutical use
FR2534582A1 (en) NOVEL BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES, USEFUL AS ANTI-HYPERURICEMIA AND ANTI-HYPERTENSION AGENTS, AND PROCESS FOR THEIR MANUFACTURE
FR2602771A1 (en) NOVEL BENZYL-4 PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA1217485A (en) 2-amino-5-aminomethyl-2-oxazolines, process for preparing the same and their use as therapeutic agents
EP0141686B1 (en) Indole derivatives, their preparation and their therapeutical application
FR2623811A1 (en) PROCESS FOR THE PREPARATION OF PHOSPHINIC ACIDS USED TO PREPARE ANGIOTENSIN CONVERSION ENZYME INHIBITORS AND INTERMEDIATES THUS OBTAINED
CH383961A (en) Process for the preparation of novel derivatives of trioxo-2,4,6-piperidine
BE779775A (en) DERIVATIVES OF UREA, METHOD FOR PREPARING THEM AND THEIR APPLICATIONS
EP0599697A1 (en) Pyrrole derivatives, their preparation and application in therapy
EP0002401B1 (en) Derivatives of naphthalene, process for their preparation and their therapeutic application
WO1992021665A1 (en) Novel oxazole derivatives and preparation thereof
EP0311467B1 (en) Use of pyrrolo[3,2,1-hi]indole derivatives in the manufacture of a medicament for the treatment of diabetes
CH425798A (en) Process for the preparation of 6-amino-penicillanic acid derivatives
FR2459242A1 (en) Antiulcer benzimidazole(s) - with 2-piperazino:methyl-1-(3-phenyl-3-hydroxypropyl) substituents
CH637649A5 (en) SYNTHESIS INTERMEDIATES FOR THE PREPARATION OF 0- (AMINO ALKYL) DIAROMATIC OXIMES.
FR2575469A1 (en) N-imidazolylmethyl-diphenylazomethines, a process for preparing them and their therapeutic application
FR2554815A2 (en) Indole derivatives, their preparation and their application in therapeutics
FR2565230A1 (en) 2-(4,5-Dihydro-1H-imidazol-2-yl)-1,2,4,5,6,7-hexahydroazepino- [3,2,1-hi]indole derivatives, their preparation and their therapeutic application
EP0125975A1 (en) Diphenylazomethines carrying an esterified chain, their preparation and their therapeutical use